Browse Category

Analyst Predictions News 8 October 2025 - 9 December 2025

Philip Morris International (PM) Stock in 2025: Smoke‑Free Pivot, Fresh EPS Guidance and What Analysts Expect Next

Philip Morris International (PM) Stock in 2025: Smoke‑Free Pivot, Fresh EPS Guidance and What Analysts Expect Next

As of December 6, 2025, Philip Morris International Inc. (NYSE: PM) sits at the center of one of the market’s most controversial but closely watched transformations: turning a legacy cigarette giant into a global “smoke‑free” consumer company. The stock trades
PepsiCo (PEP) Stock on December 2, 2025: F1 Mega-Deal, Activist Pressure, Dividend Strength and What Analysts Expect Next

PepsiCo (PEP) Stock on December 2, 2025: F1 Mega-Deal, Activist Pressure, Dividend Strength and What Analysts Expect Next

Date: December 2, 2025Ticker: PepsiCo, Inc. (NASDAQ: PEP) Key takeaways PepsiCo stock today: price, performance and valuation As of late trading on December 2, 2025, PepsiCo shares change hands around $148.68, down a fraction on the day. Recent data from
Siemens Aktiengesellschaft (SIE.DE) Stock on 2 December 2025: Buyback Momentum, 2026 Outlook and Analyst Targets

Siemens Aktiengesellschaft (SIE.DE) Stock on 2 December 2025: Buyback Momentum, 2026 Outlook and Analyst Targets

All figures and statements in this article are based on publicly available information as of 2 December 2025 and may change thereafter. This is not investment advice. Snapshot: Where Siemens stock stands today Siemens Aktiengesellschaft, the German industrial and technology
Klarna (KLAR) Stock Dips Below IPO Price – Will Analysts’ Bullish Forecast Come True?

Klarna (KLAR) Stock Dips Below IPO Price – Will Analysts’ Bullish Forecast Come True?

Ticker: KLAR (NYSE) – Price (Oct 10, 2025): $38.93 marketbeat.com. Market Cap: ~$27.9B marketbeat.com. IPO Price: $40 (opened at $52) reuters.com; 52-week high ~$57.20 investopedia.com. Active Users: 111 M; Merchants: 790 K s205.q4cdn.com. Recent Moves: Down ~6% in 5 days marketbeat.com, ~9%
12 October 2025
90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions

90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions

Current News & October 2025 Updates EMA Positive Opinion: A major recent catalyst for Acurx came on September 30, 2025, when the EMA’s Paediatric Committee issued a positive opinion on the Pediatric Investigation Plan (PIP) for Acurx’s lead drug, ibezapolstat, in Clostridioides difficile infection investing.com. This essentially
Go toTop